1672 related articles for article (PubMed ID: 27339253)
1. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and risk factors for infection after living donor liver transplantation.
Abad CL; Lahr BD; Razonable RR
Liver Transpl; 2017 Apr; 23(4):465-477. PubMed ID: 28176451
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
Kashyap R; Mantry P; Sharma R; Maloo MK; Safadjou S; Qi Y; Jain A; Maliakkal B; Ryan C; Orloff M
J Gastrointest Surg; 2009 Aug; 13(8):1480-6. PubMed ID: 19430850
[TBL] [Abstract][Full Text] [Related]
5. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
[TBL] [Abstract][Full Text] [Related]
6. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
[TBL] [Abstract][Full Text] [Related]
7. Defining long-term outcomes with living donor liver transplantation in North America.
Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
[TBL] [Abstract][Full Text] [Related]
8. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
9. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
Goldberg DS; Ruebner RL; Abt PL
Am J Transplant; 2015 Oct; 15(10):2732-8. PubMed ID: 25969133
[TBL] [Abstract][Full Text] [Related]
10. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
[TBL] [Abstract][Full Text] [Related]
11. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
[TBL] [Abstract][Full Text] [Related]
14. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score-matched analysis.
Hilmi IA; Damian D; Al-Khafaji A; Sakai T; Donaldson J; Winger DG; Kellum JA
Liver Transpl; 2015 Sep; 21(9):1179-85. PubMed ID: 25980614
[TBL] [Abstract][Full Text] [Related]
15. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
Thuluvath PJ; Yoo HY
Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
[TBL] [Abstract][Full Text] [Related]
16. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database.
Kashyap R; Safadjou S; Chen R; Mantry P; Sharma R; Patil V; Maloo M; Ryan C; Marroquin C; Barry C; Ramaraju G; Maliakkal B; Orloff M
J Gastrointest Surg; 2010 Sep; 14(9):1362-9. PubMed ID: 20617395
[TBL] [Abstract][Full Text] [Related]
17. Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study.
Samstein B; Smith AR; Freise CE; Zimmerman MA; Baker T; Olthoff KM; Fisher RA; Merion RM
Am J Transplant; 2016 Feb; 16(2):594-602. PubMed ID: 26461803
[TBL] [Abstract][Full Text] [Related]
18. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
Kling CE; Perkins JD; Reyes JD; Montenovo MI
Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
Imai D; Yoshizumi T; Sakata K; Ikegami T; Itoh S; Harada N; Motomura T; Toshima T; Mano Y; Soejima Y; Maehara Y
Transplantation; 2018 Sep; 102(9):e382-e391. PubMed ID: 29912047
[TBL] [Abstract][Full Text] [Related]
20. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
